“…In our study, MS/MS combined with massively parallel sequencing was used to detect 27 genetic metabolic diseases in newborns, including AAMD, (Shi et al, 2012) and other Asian countries, such as Singapore (1/3165) (Lim et al, 2014), Malaysia (1/2916) (Yunus et al, 2016), South Korea (1/2828) (Yoon et al, 2005), and other countries outside Asia, such as Australia (1/2700) (Estrella et al, 2014) and the USA (1/4300) (Frazier et al, 2006). Furthermore, in many cities and areas of large-scale sample research in China, the overall incidence of IEM is relatively lower than ours, for example, −1/2763 in Jiangsu province (Yang et al, 2019), 1/3444 in Guangzhou (Tang et al, 2021), 1/7030 in Taiwan (Shibata et al, 2018), 1/3163 in Suzhou (Wang et al, 2019), and 1/2804 in Quanzhou (Lin et al, 2019). These results indicate that the overall incidence of IEM in eastern coastal areas of China is greater than that in many regions.…”